Inventor
Wayne R. Gombotz
Inventor
Kenmore, WA, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides13%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
C12NMicroorganisms or enzymes6%
C12YEnzymes6%
Y10TTechnical subjects covered by former us classification6%
A61LMethods or apparatus for sterilising materials or objects in general3%
B29BPreparation or pretreatment of the material to be shaped1%
F26BDrying solid materials or objects by removing liquid therefrom1%
PatentTitleYear
11,104,714Compositions comprising a P75 tumor necrosis factor receptor/Ig fusion protein202110,683,367Compositions for inhibiting MASP-2 dependent complement activation202010,047,165Compositions for inhibiting MASP-2 dependent complement activation20189,855,256'Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures'20189,655,981'Mixed micelles'20179,518,111'Compositions comprising a p75 tumor necrosis factor receptor/Ig fusion protein'20169,475,885'Compositions for inhibiting MASP-2 dependent complement activation'20169,295,685'Mixed micelles'20169,011,860'Compositions for inhibiting MASP-2 dependent complement activation'20158,828,947'Polypeptide formulation'20148,790,696'Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures'20148,119,604'Polypeptide formulation'20127,648,702'Stable aqueous formulation of a soluble TNF receptor and arginine'20106,569,458'Process for producing small particles of biologically active molecules'20036,274,175'Prolonged release of GM-CSF'20016,120,807'Prolonged release of GM-CSF'20006,036,978'Controlled release polypeptide compositions and methods of treating inflammatory bowel disease'20005,942,253'Prolonged release of GM-CSF'19995,900,238'Vaccine delivery system'19995,451,411'Methods and compositions for the oral delivery of therapeutic agents'19955,019,400'Very low temperature casting of controlled release microspheres'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–2003Based in Lexington, MA, US· patent location history
1995–2001Based in Kirkland, WA, US· patent location history
1999–2021Patents assigned to IMMUNEX CORP (10)· patent assignee history
1999Patents assigned to AMERICAN CYANAMID CO (1)· patent assignee history
2003Patents assigned to ALKERMES INC (1)· patent assignee history
2010–2021Based in Kenmore, WA, US· patent location history
2012–2016Patents assigned to GOMBOTZ WAYNE R (4)· patent assignee history
2014–2020Patents assigned to OMEROS CORP (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNEX CORP | 10 | 1999–2021 |
| OMEROS CORP | 8 | 2014–2020 |
| GOMBOTZ WAYNE Rself | 4 | 2012–2016 |
| ALKERMES INC | 1 | 2003 |
| AMERICAN CYANAMID CO | 1 | 1999 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kenmore, Washington, US | 13 | 2010–2021 |
| Kirkland, Washington, US | 6 | 1995–2001 |
| Lexington, Massachusetts, US | 2 | 1991–2003 |